Walleye Trading’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-27,000
Closed -$2.02K 5441
2023
Q1
$2.02K Hold
27,000
﹤0.01% 4641
2022
Q4
$138 Hold
27,000
﹤0.01% 4892
2022
Q3
$2K Hold
27,000
﹤0.01% 4838
2022
Q2
$3K Hold
27,000
﹤0.01% 4909
2022
Q1
$9K Buy
+27,000
New +$10.9K ﹤0.01% 4992

Walleye Trading's LVACW Position: Q2 2023 in Review

Walleye Trading sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 27,000 shares — an estimated $2.02K sold.

Walleye Trading first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $9K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • Walleye Trading reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 27,000 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $2.02K.
  • Walleye Trading first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
  • Walleye Trading's LAVA Medtech Acquisition Corp. Warrants position peaked at $9K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.